MedTrace Logo

A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject

NCT03196557 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-12-06

No results posted yet for this study

Summary

The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects

Conditions

  • Immunoscience

Interventions

DRUG

Prenisolone

Specified dose on specified days

DRUG

Placebo

Specified dose on dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-05-05
Completion
2008-05-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03196557 on ClinicalTrials.gov